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Background/Objectives: Walking pace is associated with risk of premature mortality. 
However, whether this relationship is independent of total volume of physical activity and 
highest physical activity intensity reached remain unclear. We examined the associations 
between walking pace and cause-specific mortality, investigating the potential modifying 
effect of factors such as total physical activity volume, highest physical activity intensity, 
age, sex and BMI.   
Methods: Prospective pooled analysis of 11 population-based baseline surveys in England 
and Scotland between 1994-2008 that were linked with mortality records. Multivariate-
adjusted Cox proportional hazards models examined associations between walking pace 
(slow, average, brisk/fast) and all-cause, cancer, and CVD mortality.   
Results:  50,225 walkers were entered in the core analyses. Among participants who did not 
experience an event in the first two years of follow up (n=49,731),  walking at an average or 
brisk/fast pace was associated with a reduced risk of all-cause mortality (20% (95%CI=12-
28%) and 24% (95%CI=13-33%) respectively) and CVD mortality (24% (95%CI=9-36%) 
and 21% (95%CI=1-38%) respectively) mortality, compared  to reporting walking at a slow 
pace. In stratified analyses, such associations were evident amongst those over 50 years, 
those not meeting the physical activity recommendations, and those who did not undertake 
vigorous intensity activity. There was no interactions by sex or BMI. No associations were 
seen between pace and cancer mortality. 
Conclusion: Walking i benefits health. Assuming causality, these analyses suggest that in-
creasing walking pace could reduce risk for all-cause and CVD mortality. Walking pace 
could be emphasised in public health messages, especially in situations when increase in 
walking volume or frequency is less feasible. 
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Increasing population level walking remains a key focus of physical activity (PA) promotion. 
Regular walking is known to confer many physical, mental and social health benefits.1 Meta-
analyses of cohort studies have sought to quantify the association between regular walking 
and reduction in risk for all-cause mortality (ACM).2-4 Kelly et al., (2014) estimated that after 
adjustment for other PA, walking at a volume equivalent to PA guidelines was associated 
with an 11% reduction in risk for ACM compared to no walking.5  
 
Considering specific health endpoints,  cardiovascular disease (CVD)  and cancer are the two 
most common avoidable causes of mortality in the UK.6  Hamer and Chida (2008) conducted 
a meta-analysis of 13 cohort studies and found a 31% reduction in risk of CVD mortality in 
the highest walking categories compared with the lowest walking volume/intensity category.2 
A recent, large analysis of over 250,000 adults in the UK found walking commuting was 
associated with a 36% reduction in risk of CVD mortality compared to non-active 
commuting.7 The results for cancer mortality are less clear, with, for example, Matthews et 
al., (2007) and Celis-Morales (2017) finding no significant associations between walking 
volume and cancer mortality in large cohort studies.7 8  
 
According to principles of overload, a higher relative activity intensity achieved by a faster 
pace of walking would provide the stimulus to produce a greater physiological response, and 
more substantial or even additional health benefits. Acute studies have shown that walking at 
a faster pace results in greater physiological responses1. However, while total volume of 
walking e.g. by distance or time has been frequently studied2-5, less is known about the long-
term health effects of habitual walking pace. 
 




A Copenhagen City Heart Study analysis9 reported reduced risk of heart failure for moderate 
and high walking speed compared to slow speed. The authors also suggested that walking 
pace may have a stronger association with heart failure than total duration of walking. Man-
son et al.,10  found that among 73,743 postmenopausal women aged 50-79 years walking pace 
was associated with reduced incidence of CVD in a dose-response fashion. In a 40-year fol-
low up of the Whitehall study of 6,981 British civil servants, Batty et al.,11 compared slow 
walking pace to high walking pace and found a reduced risk of all-cause, coronary heart dis-
ease (CHD), and total cancer mortality. None of these studies adjusted for total volume of PA 
and it is therefore unclear if the reported effects were partly attributable to the higher overall 
activity levels of brisk/fast walkers.  
  
A recent analysis of 420,000 UK Biobank Participants found significant associations between 
higher walking pace and reduced risk of all-cause and CVD mortality, but inconsistent find-
ings for cancer mortality12.  However, the UK Biobank had a response rate of 5.5% and con-
cerns have been raised about the generalisability of non-genetic associations from very unrep-
resentative cohorts13.  
 
In summary, walking pace has been found to be associated with reduced risk of all-cause and 
cause-specific mortality in a number of cohort studies but the literature on the whole has not 
addressed independence from total PA robustly. There remains a knowledge gap about the 
independence of the relationships between walking pace and mortality outcomes in large pop-
ulation cohorts.  
 
Our aim was to examine the associations between self-reported walking pace with all-cause, 
CVD and cancer mortality in a population representative sample of 11 pooled population 




British cohorts. A secondary aim was to better understand the role of total and total PA, sex, 




The Health Survey for England (HSE)14  and the Scottish Health Survey (SHeS)15 are estab-
lished household-based population surveillance studies running since 1991 and 1995, respec-
tively. Each year samples are selected using a multistage, stratified probability design aimed 
at recruiting a nationally representative sample of adults living in private households. Trained 
interviewers visited the selected households, and the recruited participants were administered 
the study questionnaires. 91.6% of survey participants gave written consent to have their 
death flagged on the NHS Central Mortality Register. For this analysis we used data from 
HSE 1994, 1997, 1998, 1999, 2003, 2004, 2006 and 2008 and SHeS 1995, 1998 and 2003.  
As population mortality rates increase evidently from the 4th decade of life, we included indi-
viduals aged ≥30 years old who reported at least one occasion of walking in the last four 
weeks, had no doctor-diagnosed or self-reported (long standing illness module) ischemic 
heart disease, angina, or stroke, and no prevalent cancer through cancer registration records 
or self-reported (long standing illness module).   An occasion of walking was variously de-
fined as at least 10 minutes or at least 15 minutes or at least 30 minutes in the different base-
line surveys16. Each baseline survey was approved by the relevant Research Ethics Commit-
tees in England and Scotland.   
 
Mortality outcomes 




Participants were followed up for mortality until 31/12/2009 (SHeS) or 31/03/2011 (HSE).  
Diagnoses for primary causes of death were recorded according to the International Classifi-
cation of Diseases, Ninth Revision (ICD9) and Tenth Revision (ICD10). Cancer deaths were 
identified using ICD9 140.0-239.9 and ICD10 C00.0-D48.9 codes; CVD deaths were identi-
fied using ICD9 390.0-459.9 and ICD10 I01.0-I99 codes. 
 
Assessment of walking and other physical activity 
PA was assessed using an interviewer-administered questionnaire that inquired about walk-
ing, domestic PA, and participation in sports and exercises in the four weeks prior to the in-
terview16.  Walking was assessed using a question on number of days walked in the last 4 
weeks, the average amount of time spent walking on each day, and the usual walking pace 
(“which of the following describes your usual walking pace: slow pace, average pace, fairly 
brisk pace, fast pace-at least 4mph”).  Because some baseline surveys (HSE 
1994/1999/2003/2004; SHeS 1995) did not enquire about walking duration per reported occa-
sion we imputed this information based on the age and sex-specific estimates of HSE 
1997/1998  (that included duration questions)  using methods described elsewhere17. All PA 
variables were summarized to reflect weekly averages for easier comparison with currently 
recommended amounts. The criterion validity of the walking-related questions is unknown. 
In a convergent validity study of over 2000 adults, the Spearman correlation coefficients be-
tween accelerometry counts and walking of brisk/fast pace were 0.35 (95% confidence 
interval (CI): 0.31, 0.40) for women and 0.28 (95%CI: 0.23, 0.34) for men18.  The equivalent 
coefficients for total weekly questionnaire derived Metabolic Equivalents (MET)-minutes 
were 0.41 (95%CI: 0.36, 0.46) for women and 0.32 (95%CI: 0.26, 0.38) for men18.    
 




The PA compendium19 was used to assign the MET for all PAs to calculate total MET-
hours/week. We estimated adherence to the general guideline20  as accumulating weekly at 
least 150 minutes of moderate intensity or 75 minutes of vigorous intensity or equivalent 
combinations of moderate and vigorous PA20.  We also calculated highest physical activity 
intensity reached on at least one occasion over the  last four weeks that the PA questionaire 
time frame covered (light/moderate/vigorous).  
 
Covariates 
Height and weight were measured by the interviewers using standard protocols14 15; body 
mass index (BMI) was calculated as weight (in kilograms) divided by height (in meters) 
squared.  Additional questions assessed age, educational attainment (age completed full time 
education), presence of longstanding illness, weekly frequency of alcohol consumption, 
smoking habits (never smoker, ex-smoker, currently smoking 1-9 cigarettes/day, currently 
smoking 10-19/day, currently smoking ≥20/day), psychological distress/depression (12-point 
General Health Questionnaire score, GHQ), total (non-walking) leisure time PA volume 
(MET-hours/week) and total walking volume (MET-hours/week), and highest PA intensity 
reached on at least one occasion.   
 
Statistical analysis  
Analyses were conducted using SPSS version 22 (SPSS, Inc). Cox proportional-hazard mod-
els with time in study as the time-scale were used to examine the associations between walk-
ing pace and all-cause, CVD, and cancer mortality with “slow pace” as the reference cate-
gory. Walking pace was originally entered in its original 4 categories format but the low 
number of events in the “fast pace” category resulted in unstable estimates and broad 95% 




CIs; for this reason, all main analyses were carried out with “fairly brisk” and “fast” pace cat-
egories collapsed into one group. In a supplemental analysis we entered walking pace in its 
original format.      
 
Kaplan Meier log-minus-log plots were used to examine the proportional-hazards assumption 
and no violations were observed.  Analyses were adjusted for age, sex, and all covariates 
listed above. Occupational PA could not be used in the calculation of PA volume because of 
its non-quantitative nature (it was reported as very/fairly/not very/not at all physically active). 
Also, we chose not to adjust for occupational PA level in the main Cox models because of the 
large number of missing values (n≈27,000) due to the corresponding question missing from 
SHeS 1995 and for responses being dependant on employment status.    
 
We examined effect modification by sex, age, and total  PA level using Type 3 Wald chi-
square statistics for the interaction term in the partially adjusted (for age, sex, and co-
hort/year) model. For interactions with p<0.010 we performed stratified analyses20.  To mini-
mize the possibility of spurious associations due to occult disease we ran a sensitivity analy-
sis where we both included and excluded participants who died in the first 24 months of fol-




In total, 65,381 participants were initially considered; 4,811 participants (8.4% of total 
eligible) did not consent to follow up and were excluded. The variables with the highest 
number of missing data were BMI (n=6,346), GHQ score (n=2,444) and smoking (n=151). In 
total, there were 3617 deaths from any cause including 1014 from CVD and 1276 from 




cancer causes. The mean follow up was 9.2 (SD=4.6) years, corresponding to 469,235 person 
years. Table 1 presents the sample characteristics for the 50,225 individuals in the analytical 
sample. Slower walking pace was associated with older age, female sex, higher BMI scores, 
reporting a long-standing illness at baseline, and indications of psychological distress. Faster 
walking pace was associated with being a smoker, high frequency of alcohol consumption, 
finishing education after age 19 years, meeting the PA recommendations, participating in 
higher intensity PA, high volumes of total non-occupational PA, and higher frequency and 
total walking volume. Walking pace (in its original 4-group format) showed low magnitude 
correlations with total leisure time PA volume (Spearman rho=0.25) and walking volume 
(rho=0.20). 
 
Table 2 presents the associations between walking pace and the three mortality outcomes 
with all participants who had an event in the first 24 months of the follow-up excluded 
(n=49,731). In the fully adjusted models, walking at an average pace was associated with a 
risk reduction for ACM of 20% (95%CI:12-28%) compared with those walking at a slow 
pace. The respective risk reduction for those walking at brisk/fast pace was 24% (13-33%). 
For CVD mortality, walking at an average pace was associated with a 24% (9-36%) risk 
reduction and walking at a brisk/fast pace was associated with 21% (1-38%) risk reduction 
compared with those walking at a slow pace. There was no evidence to suggest walking at an 
average or brisk/fast pace was associated with a significant risk reduction in cancer mortality 
(hazard ratio (HR)=1.08 (0.89-1.31) and HR=1.02 (0.81-1.29) respectively). The results were 
similar in direction and magnitude when those who had an event in the first 24 months were 
included (Supplemental Table 1). When the walking pace variable was entered in its 
original 4-group format (Supplemental Table 2) associations were similar in magnitude and 
direction but likely due to lower number of events, the 95% CI of the fast pace group were 




very wide and included 1 for all three outcomes. Repeating all above analyses with the 
models adjusted for total duration of MVPA and light intensity activity (instead of average 
MET-hours per week) produced almost identical results, for example the HR(95%CI) for 
ACM in the average pace group changed from 0.80 (0.72 to 0.88) to 0.80 (0.73 to 0.88);  in 
the brisk/fast group it changed from 0.76 (0.67, 0.87) to 0.77 (0.68, 0.88)  (data available on 
request).  
 
There were statistically significant interaction effects of walking pace and total PA volume 
(e.g. p=0.038 for ACM) and highest intensity reached (e.g. p=0.004 for ACM). Significant 
interaction effects were also found for walking pace and age (e.g. p=0.005 for ACM) but not 
for sex or BMI.  
 
Stratified analyses by age in two and three groups are presented in Figure 1 and Supplemental 
Figure 1 respectively, and by compliance with the PA recommendations in Figure 2. Figure 1 
shows clearer evidence of a relationship between walking pace and all-cause and CVD 
mortality, but not cancer mortality, in the over 50s compared to the results for the whole 
sample. There was little evidence of association in the under 50s. Supplemental Figure 1 
showed clearer evidence for a relationship of walking pace with all-cause mortality in those 
aged 45-59 and ≥60 years and with CVD mortality in those aged ≥60 years.  
 
Figure 2 shows clearer evidence of a relationship between walking pace and all-cause and 
CVD mortality, but not cancer mortality, amongst those that did not meet the PA guidelines    
compared to the results of the whole sample. For those meeting the guidelines, the direction 
of effect for all cause and CVD mortality was protective for increasing pace, but very low 
number of events caused low power and wide confidence intervals.  





Figure 3 shows the stratified analyses of walking pace and all-cause and CVD mortality by 
highest intensity reached; analyses were not performed for cancer mortality due to the low 
number of events in some cells and the apparent violation of the proportional hazards 
assumption. There was evidence of a relationship between walking pace and ACM in both 
the light and moderate intensity groups. There was some evidence for a relationship with 
CVD mortality in these groups although confidence intervals were wider and there was no 
dose-response. There was no evidence of a relationship between walking pace and all-cause 
or CVD mortality amongst the group that reported reaching vigorous intensity.  
 
DISCUSSION  
In adults in Scotland and England, walking at average or brisk/fast pace was associated with a 
reduced risk of all-cause and CVD mortality compared with walking at slow pace. However, 
there was no evidence of a similar relationship with cancer mortality. Our findings are in 
agreement with previous studies which have reported that a higher pace of walking was 
associated with a risk reduction for ACM of between 19%21 and 42%11. Our estimates are 
within this range, and adjusted for total volume of both walking and non-walking PA (MET-
hrs/week),   and highest PA intensity reached. We found that the associations between pace 
and ACM persisted after controlling for total leisure time PA which is consistent with studies 
that controlled for total walking energy expenditure22 and moderate to vigorous PA12.  Batty 
et al., reported a 20% reduction in cancer mortality for walking fast.11 Similar to Yates et al., 
(2017)12 we did not find any evidence of this effect.   
 
Possible explanations 




The association between pace on all-cause and CVD mortality may be explained by the 
increased relative exercise intensity elicited by a faster pace providing a greater stimulus for 
physiologic adaptations23 in functions known to influence CVD mortality. This may be 
further confirmed by the observation that the associations of walking pace with ACM and (in 
particular) CVD mortality were considerably weakened for the subsample of participants that 
have achieved vigorous intensity in non-walking physical activity.  
 
We did not find an effect of pace on cancer mortality. Volume may be more important than 
pace for cancer mortality. Alternatively we know that different cancers have different 
relationships with PA, and that if we had examined mortality from specific malignancies e.g., 
breast and colon cancer a relationship may have been observed24.  
 
We did not find evidence for associations for the younger participants, the physically active, 
or for those reaching vigorous intensity, but recommend caution when interpreting these 
findings. Low number of events in strata increased uncertainty. It is possible that older age 
and lower PA status (total or intensity) predict lower aerobic fitness (maximal oxygen 
consumption). As such, that the relative intensity of walking at faster pace may be equivalent 
to the upper end of moderate intensity or even vigorous intensity, and therefore provides a 
greater physiological stimulus for maintaining cardiovascular function and promoting health.  
 
Separating the effect of one specific aspect of physical activity and understanding its 
potentially causal association with mortality is complex.  Our analyses suggest that 
participants who usually walk at a brisk/fast pace are overall the most active and probably the 
healthiest. ,Although it is biologically plausible that walking at a higher pace leads to better 
health overall and cardiovascular health specifically, it is also likely that walking at a faster 




pace is a marker for better health, fitness, and physical function, which predicts the risk for 
mortality in the following years. In other words, walking pace may be a predictor of lower 
mortality risk, a causal factor, or a both.  
 
Strengths and limitations 
The strengths of the present study include the large sample comprising a series of baseline 
surveys that were roughly representative of the population in England and Scotland, the very 
high response rates, and the relatively long follow up. The results can be generalised to the 
UK population with more confidence than previous estimates. To our knowledge this is the 
first such study to report associations between walking pace and all-cause, CVD, and cancer 
mortality and adjust for total (walking and non-walking) PA volume and highest intensity 
reached. We also present novel analysis of associations stratified by age, total PA and highest 
intensity reached to investigate important potential effect modifiers.  
 
Limitations include the exposure “walking pace” and all other PA variables were self-
reported and therefore subject to misclassification and other biases. Further misclassification 
may have been introduced by the imputation of walking duration for a number of baseline 
surveys17, and this may be partly the reason why adjustments for total walking volume  had 
negligible impact on the estimates.  The repeated cross-sectional nature of HSE and SHeS 
meant we could not assess or account for temporal changes in walking behavior within 
individuals. The analyses controlled for a comprehensive set of covariates in addition to PA, 
although we cannot discount the possibility of residual confounding. Some stratified analyses 
had too few events and therefore may not have been powerful enough to detect associations 
or lack of association with confidence.    
 




Implications and future research 
The additional protective effect demonstrated from higher walking pace may have 
implications for public health messaging.  Walking is a cornerstone of PA promotion for 
public health, but volume of walking (steps per day) has often been emphasised.  Given the 
perceived time barrier cited by those who fail to meet current PA guidelines25, a pace change 
could be more feasible (for those with adequate physical capacity) than increased volume or 
duration. We encourage the Chief Medical Officers’ Physical Activity Guidelines Committee 
to consider this in their upcoming revision of the PA Guidelines. Further experimental 
research is warranted to establish if a randomised intervention based on pace elicits important 
physiological change26.   
 
Conclusions 
Walking is known to benefit health. Assuming causal relationships, these analyses suggest 
that increasing walking pace could be linked with lower risk for all-cause and CVD mortality. 
Walking pace should be emphasised in public health messages, especially in circumstances 
when increase in walking volume or frequency is less feasible. 
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FIGURE LEGENDS  
 
Figure 1: Associations between walking pace (3 groups)  and all-cause, cardiovascular dis-
ease, and cancer mortality by age group (<50 vs. ≥50 years) a.  Walkers aged 30 years and 
over with no diagnosed cardiovascular disease or cancer at baseline b.  The Health Survey for 
England and Scottish Health Survey.   
 
 
50 years of age was selected as a cutoff point due to its proximity to median age for this sample (48 
years)  b Prevalent cardiovascular disease was defined as doctor-diagnosed or self-reported (long 
standing illness module) ischemic heart disease, angina, or stroke; prevalent cancer was determined 
through cancer registration records or self-reported (long standing illness module) cModel adjusted for  
sex,   cohort,   long-standing illness, alcohol drinking frequency, psychological distress, body mass 
index, smoking status, education level,  total (non-walking) physical activity volume (MET-
hrs/week), walking volume (MET-hrs/week), and  highest physical activity intensity reached. 
 
 
Figure 2: Associations between walking pace (3 groups)  and all-cause, cardiovascular dis-
ease, and cancer mortality,  by physical activity level (meeting  vs. not meeting the physical 
activity recommendations).a Walkers aged 30 years and over with no diagnosed cardiovascu-
lar disease or cancer at baseline b.  The Health Survey for England and Scottish Health Sur-
vey.   
 
a Adherence to the physical activity recommendations was defined as at least 150 minutes of moder-
ate-intensity activity or 75 minutes per week of vigorous intensity activity or equivalent combinatins 
of moderate and vigorous activity b Prevalent cardiovascular disease was defined as doctor-diagnosed 
or self-reported (long standing illness module) ischemic heart disease, angina, or stroke; prevalent 
cancer was determined through cancer registration records or self-reported (long standing illness mod-
ule) cModel adjusted for  sex,   cohort,   long-standing illness, alcohol drinking frequency, psychologi-
cal distress, body mass index, smoking status, education level, walking volume (MET-hrs/week), 
highest physical activity intensity reached. 
 
 
Figure 3: Associations between walking pace (3 groups)  and all-cause, and cardiovascular 
disease mortality, by highest physical activity intensity reached (light/moderate/vigorous). 
Walkers aged 30 years and over with no diagnosed cardiovascular disease or cancer at base-
line a.  The Health Survey for England and Scottish Health Survey.   
 
a Prevalent cardiovascular disease was defined as doctor-diagnosed or self-reported (long standing ill-
ness module) ischemic heart disease, angina, or stroke; prevalent cancer was determined through can-
cer registration records or self-reported (long standing illness module) bModel adjusted for  sex,   co-
hort,   long-standing illness, alcohol drinking frequency, psychological distress, body mass index, 
smoking status, education level, walking volume (MET-hrs/week), and total (non-walking) physical 
activity volume (MET-hrs/week).  





  Table 1.  Baseline characteristics of the sample by walking pace. Walkers aged 30 years and over with no diagnosed cardiovascular 
disease or cancer at baseline.  The Health Survey for England and Scottish Health Survey (n=50,225).   
 Walking Pace  
 Slow Pace Average Pace Fairly Brisk 
Pace 
Fast Pace   
     Pe    
Age, mean (SD) (years) 57.8 51.1 47.7 44.6 <0.001 
Sex (% female) 61.0 58.5 52.2 40.5 <0.001 
Body mass index, mean (SD) (kg/m2)  28.6 (5.7) 27.3 (4.7) 26.1 (4.1) 25.5 (3.9) <0.001 
Long standing illness a (%) 64.6 41.9 35.4 33.0 <0.001 
Smoking (% current) 23.9 24.0 21.5 27.5 <0.001 
Alcohol frequency (% ≥5 times/week)b 18.7 18.7 22.4 24.5 <0.001 
Psychological distress  (% with General 
Health Questionnaire score ≥4)c 
20.1 11.9 11.6 12.2 <0.001 
Age finished education (% finished age 
19+) 
12.9 18.1 26.3 29.0 <0.001 
Meeting the physical activity recommen-
dations d  
8.9 17.2 47.5 52.4 <0.001 
Highest PA intensity reached (%) 
No physical activity  
Light intensity  only 
Reached moderate inensity  























MET-hours of physical activity per week, 
median (SE) 
8.0 (0.38) 17.0 (0.20) 23.1 (0.31) 32.0 (0.80) <0.001 
Number of days walked per week, median 
(SE) 
2.0 (0.04) 2.5 (0.02) 2.5 (0.02) 3.0 (0.05) <0.001 
MET-hours of walking per week (any 
pace), median (SE) 
2.3.5 (0.12) 4.9 (0.08) 6.1 (0.12) 9.4 (0.39) <0.001 




aDichotomous variable derived from responses to a series of questions (yes/no) on illness within 8 listed body systems (eg. nervous system, digestive sys-
tem, heart and circulatory system etc.). At least one illness required to have longstanding illness;b derived from the question “on how many days in the last 
7 days did you have an alcoholic drink; c General Health Questionnaire comprises 12 questions related to psychological health (eg. concentration, feeling 
depressed etc) the categories were 0, 1-3 and ≥4;  d at least 150 minutes of moderate-intensity activity or 75 minutes per week of vigorous intensity activity 
or equivalent combinatins of moderate and vigorous activity;); e P-value calculated using Kruskal-Wallis test for continuous variables and likelihood ratio 
chi-square test for categorical variables.  
 




Table 2:   Associations between walking pace (3 groups) and all-cause, cardiovascular disease, and cancer mortality.  Walkers aged 30 
years and over with no diagnosed cardiovascular disease or cancer at baselinea excluding deaths occurring the first 24 months of follow 
up.  The Health Survey for England and Scottish Health Survey (n=49,731).   
 
Deaths/n 
Model 1b Model 2c Model 3d 
HR 95% CIs HR 95% CIs HR 95% CIs 
All-cause Mortality        
Walking Pace          
Slow  576/4101 1  1  1  
Average 1957/25857 0.73 0.67,0.81 0.78 0.71,0.87 0.80 0.72,0.88 
Brisk/Fast 730/19773 0.61 0.55,0.69 0.68 0.61,0.77 0.76 0.67,0.87 
P trend linear  <0.001  <0.001  <0.001  
P trend nonlinear  <0.001  0.003  0.001  
        
Cardiovascular Mor-
tality 
       
Walking Pace          
Slow  192/4101 1  1  1  
Average 552/25857 0.68 0.57,0.81 0.75 0.63,0.90 0.76 0.64,0.91 
Brisk/Fast 193/19773 0.55 0.45,0.68 0.67 0.54,0.83 0.79 0.62, 0.99 
P trend linear  <0.001  0.001  0.089  
P trend nonlinear  0.007  0.032  0.007  
        
Cancer Mortality        
Walking Pace          
Slow  137/4101 1  1  1  
Average 717/25857 1.03 0.85,1.24 1.06 0.88,1.29 1.08 0.89,1.31 
Brisk/Fast 297/19773 0.88 0.71,1.08 0.95 0.76, 1.17 1.02 0.81,1.29 
P trend linear  0.152  0.478  0.945  
P trend nonlinear  0.338  0.269  0.339  
a Prevalent cardiovascular disease was defined as doctor-diagnosed or self-reported (long standing illness module) ischemic heart disease, angina, or stroke; 
prevalent cancer was determined through cancer registration records or self-reported (long standing illness module) bModel adjusted for age,    sex, and 
cohort;   cModel also adjusted for  long-standing illness, alcohol drinking frequency, psychological distress, body mass index, smoking status, education 





level;   dModel also adjusted for total (non-walking) physical activity volume (MET-hrs/week),  walking volume (MET-hrs/week), and  highest physical 
activity intensity reached. 
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